Associate Director, Analytical Development & CMC Statistics

About Summit:

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life increasing potential duration of life and resolving serious unmet medical needs. At Summit we believe in building a team of world class professionals who are passionate about this mission and it is our people who drive this mission to reality. Summits core values include integrity passion for excellence purposeful urgency collaboration and our commitment to people. Our employees are truly the heart and soul of our culture and they are invaluable in shaping our journey toward excellence.

Summits team is inspired to touch and help change lives through Summits clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies including:

Non-small Cell Lung Cancer (NSCLC)

• HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.

• HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.

• HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.

Colorectal Cancer (CRC)

• HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than Chinas National Medical Products Administration (NMPA). Summit is headquartered in Miami Florida and has additional offices in California New Jersey the UK and Ireland.

Overview of Role:

TheAssociateDirector of Analytical Development and CMC Statistics will provide technical and statistical leadership for analytical development method validation method transfer comparability stability specifications and lifecycle management activities supporting biologic drug substance and drug product programs. This role will sit within the CMC Analytical Sciences organization and will partner closely with Analytical MSAT Quality Regulatory Affairs Supply Chain and external CDMOs/CROs to ensure that analytical strategies statistical approaches and data packages are scientifically robust phase-appropriate compliant and suitable for global regulatory submissions and commercial readiness.

The successful candidate will combine hands-on experience in biologics analytical development with strong statisticalexpertise including method validation statistics stability and shelf-life modeling specification setting comparability assessments assay lifecycle monitoring and statistical support for CMC investigations. This individual will be expected to translate complex analytical datasets into clear conclusions support risk-based decision-making and contribute directly to IND/IMPD BLA/MAA post-approval and health authority response activities.

Role and Responsibilities:

• Provide scientific and technical leadership for analytical method development qualification validation transfer troubleshooting and lifecycle management for biologic drug substance and drug product programs.
• Support phase-appropriate analytical strategies for release stability characterization comparability potency binding impurity and residual testing.
• Review and interpret analytical data from CDMOs CROs and partner laboratories to ensure methods are robust fit for purpose and aligned with regulatory expectations.
• Contribute to analytical control strategy development including critical quality attribute assessment method performance monitoring and product quality trend evaluation.
• Lead statistical planning analysis and interpretation for analytical method validation method transfer comparability stability specification setting assay qualification and investigation support.
• Applyappropriate statisticaltools to evaluate accuracy precision linearity range robustness intermediate precision equivalence trending outliers assay variability and method capability.
• Develop and justify statistically sound acceptance criteria comparability criteria stability models DS and DP shelf-life determinations stability trending approaches and analytical control limits.
• Partner with CMC Quality Regulatory Affairs and external partners to ensure statistical approaches are scientifically defensible and clearly documented in protocols reports and regulatory submissions.
• Support data visualization multivariate analysis and trendmonitoringto enable early identification of analytical or manufacturing risks.
• Supportinspectionreadiness audit responses regulatory commitments and post-approval lifecycle management activities related to analytical methods stability specifications and comparability.
• Provide statistical input into deviations OOS/OOT investigations CAPAs change controls and risk assessments.
• Provide analytical and statistical oversight for external CDMOs CROs and partner laboratories performing release stability characterization method transfer method validation and comparability studies.
• Review external protocols reports data packages deviations and investigations to ensure technical quality compliance and alignment with programobjectives.
• Communicate complex analytical and statistical findings clearly to technical and non-technical stakeholders including senior leadership.
• Contribute to internal SOPs templates best practices and governance processes for analytical development CMC statistics and outsourced analytical activities.
• All other duties as assigned.

Experience Education and Specialized Knowledge and Skills:

• Advanced degree(s) preferred in Statistics Biostatistics Analytical Chemistry Biochemistry Pharmaceutical Sciences Chemical Engineering or a related scientific discipline;Bachelors or mastersdegree with substantial relevant experience will be considered.
• Minimum of10 years of relevant experience in the biopharmaceutical or pharmaceutical industry including direct experience supporting CMC analytical development and/or process development and manufacturing activities.
• Strong knowledge and understanding of biologics analytical methods including chromatographic electrophoretic immunoassay potency binding impurity and/or process residuals.
• Demonstrated experience with analytical method development validation method transfer comparability specification setting stability analysis and statistical analysis & interpretation of CMC datasets.
• Working knowledge of ICHFDAand EMA guidance and GMP regulation as well as data integrity expectations relevant to analytical development and lifecycle management.
• Experience reviewing or authoring protocols reports regulatory submission sections health authority responses deviations OOS/OOT investigations CAPAs and change controls.
• Travel may be required periodically to support CDMO/CRO oversight technical meetings regulatory interactions or cross-functional workshops.

Actual compensation packages are based on several factors that are unique to each candidate including but not limited to skill set depth of experience certifications and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus stock benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summits Talent Acquisition team atto obtain prior written authorization before referring any candidates to Summit.

Summit Therapeutics an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment hiring training or promotion or any other employment practices for reasons of race color religion gender national origin age sexual orientation marital or veteran status disability or any other legally protected status.